Business of the House

Nick Thomas-Symonds Excerpts

Thursday 7th December 2017 Commons Chamber

[Andrea Leadsom]

I thank my hon. Friend for raising this very important matter, which was of great concern to my constituents and, indeed, yours, Mr Speaker, during the first phase of HS2. I continue to challenge HS2 Ltd on a number of constituents’ house purchase matters that have been long outstanding. I urge my hon. Friend to seek an Adjournment debate or a Westminster Hall debate to get a further response from Ministers on what more can be done to ensure that HS2 Ltd is addressing all constituents’ concerns fairly.

[Nick Thomas-Symonds (Torfaen) (Lab)]

The Association of Medical Research Charities has now published its report on greater access to off-patent drugs on the frontline, to which many stakeholders have contributed, including me as chair of the all-party parliamentary group on off-patent drugs. May we have a debate on how to continue our cross-party agenda to increase access to off-patent drugs?

[Andrea Leadsom]

All Members have particular constituency issues concerning off-patent drugs, which is an incredibly important area. I see that there are Health questions on 19 December, so the hon. Gentleman might want to raise it then. I am sure there would be a lot of demand from Members for a debate on the subject.